Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy

Compositions and methods for modulating innate and adaptive immunity and for use in immunotherapy are disclosed. In particular, the invention relates to novel ganciclovir derivatives and methods of using them for the treatment of immune-related disorders, including inflammation, autoimmunity, and infections, and neurological disorders, and cancer.


Year:
2017
Keywords:
Other identifiers:
EPO Family ID: 58157430
Laboratories:




 Record created 2017-12-01, last modified 2019-12-05

External link:
Download fulltext
URL
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)